Description
UPDATE CONTRACTOR POC
Base award description: NEW AWARD FOR GLATIRAMER ACETATE INJECTIONS WITH TEVA PHARMACEUTICALS USA, INC. ORDERING PERIOD IS AUGUST 5, 2023 TO AUGUST 4, 2024 WITH FOUR ONE-YEAR OPTIONS.
First action · last action
2023-06-06 · 2026-08-10
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$64,352,515
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 13 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-06-06+$0= $0
- Mod P000012023-06-07+$0= $0
- Mod P000022023-12-12+$0= $0
- Mod P000032023-12-18+$0= $0
- Mod P000042024-03-07+$0= $0
- Mod P000052024-07-09+$0= $0
- Mod P000062024-12-04+$0= $0
- Mod P000072025-01-06+$0= $0
- Mod P000082025-06-25+$0= $0
- Mod P000092025-12-03+$0= $0
- Mod P000102026-01-05+$0= $0
- Mod P000112026-07-07+$0= $0
- Mod P000122026-08-10+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-06-06 | +$0 | $0 | NEW AWARD FOR GLATIRAMER ACETATE INJECTIONS WITH TEVA PHARMACEUTICALS USA, INC. ORDERING PERIOD IS AUGUST 5, 2… |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2023-06-07 | +$0 | $0 | INCORPORATION OF DRUG SUPPLY CHAIN SECURITY ACT (DSCSA) LANGUAGE |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2023-12-12 | +$0 | $0 | INCORPORATION 2024 FEDERAL CEILING PRICES INTO NATIONAL CONTRACT. NO CHANGES TO NATIONAL CONTRACT PRICE, AS IT… |
| Mod P00003· ADD SUBCONTRACTING PLAN | 2023-12-18 | +$0 | $0 | INCORPORATION OF 2024 SMALL BUSINESS SUBCONTRACTING PLAN INTO CONTRACT. |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-03-07 | +$0 | $0 | CHANGE TIMEFRAME FOR THE SUBMISSION OF QUARTERLY SALES REPORTS AND COST RECOVERY FEE TO 30 CALENDAR DAYS AFTER… |
| Mod P00005· EXERCISE AN OPTION | 2024-07-09 | +$0 | $0 | EXERCISE THE FIRST OPTION YEAR FOR GLATIRAMER ACETATE INJECTIONS CONTRACT 36E79723D0023 WITH TEVA PHARMACEUTIC… |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2024-12-04 | +$0 | $0 | INCORPORATE 2025 FEDERAL CEILING PRICES INTO CONTRACT. NO CHANGES TO AWARDED NATIONAL CONTRACT PRICES. |
| Mod P00007· ADD SUBCONTRACTING PLAN | 2025-01-06 | +$0 | $0 | INCORPORATE 2025 SMALL BUSINESS SUBCONTRACTING PLAN INTO CONTRACT. |
| Mod P00008· EXERCISE AN OPTION | 2025-06-25 | +$0 | $0 | EXERCISE THE SECOND OPTION YEAR FOR GLATIRAMER ACETATE INJECTIONS CONTRACT 36E79723D0023 WITH TEVA PHARMACEUTI… |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2025-12-03 | +$0 | $0 | INCORPORATION 2026 FEDERAL CEILING PRICES INTO NATIONAL CONTRACT. NO CHANGES TO NATIONAL CONTRACT PRICE, AS IT… |
| Mod P00010· ADD SUBCONTRACTING PLAN | 2026-01-05 | +$0 | $0 | INCORPORATION OF THE 2026 APPROVED SUBK PLAN. |
| Mod P00011· EXERCISE AN OPTION | 2026-07-07 | +$0 | $0 | EXERCISE THE 3RD YEAR FOR GLATIRAMER ACETATE INJECTIONS CONTRACT 36E79723D0023 WITH TEVA PHARMACEUTICALS USA,… |
| Mod P00012· OTHER ADMINISTRATIVE ACTION | 2026-08-10 | +$0 | $0 | UPDATE CONTRACTOR POC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NEN9A34LRHJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0125 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79722D0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| VA797E17A0007 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2018 |
| V797D70217 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA797E17C0034 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA797E17C0033 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79723D0023_3600 · retrieved 2026-09-26.